Electrophysiological characteristics of mitral annular septum originated focal atrial tachycardia and therapy of radiofrequency ablation for it

Yun-long WANG,Zhuo LIANG,Yun WANG,Zhi-hong HAN,Ye WANG,Xue-jun REN,Xue-bin LI
DOI: https://doi.org/10.3969/j.issn.1674-4055.2016.12.16
2016-01-01
Abstract:Objective To investigate the characteristics of electrocardiogram (ECG) and electrophysiology of mitral annular septum originated focal atrial tachycardia (AT) and therapy of radiofrequency ablation (RFA) for it. Methods The patients with confirmed mitral annular septum originated focal atrial tachycardia (mitral AT) were diagnosed by intracardiac electrophysiological examination (n=13, male 6, female 7, aged from 23 to 47 and average age=35±12) and their medical history was from 1 to 6 y.Results The transseptal mapping and RFA were success in 12 cases and transaortic retrograde mapping and RFA were success in 1 case. According to local potential features, the RFA sites confirmed by X-ray photograph and 3-D mapping system and given RFA successfully were as follows: beside of anterior mitral annular septum (in 8 cases), between medium and anterior mitral annular septum (in 3 cases) and beside of posterior mitral annular septum (in 2 cases). P wave in lead V1 of ECG in all patients showed both negative and positive phases. The right atrial electric activation mapping showed that the right atrial earliest activation site was located in side of mitral annular septum (His bundle zone or proximal coronary sinus). The local potential in successful target spots all showed micro-A-wave and macro-V-wave in 13 cases, and local potential of A-wave was complicated or cataclastic in 9 cases. All patients had no significant complications, and 12 cases had no re-attack of mitral AT after a long-term follow-up.Conclusion The zones surrounding mitral annular septum are important originating sites of mitral AT, and a common one beside anterior mitral annular septum with special P wave and sequence of intracardiac activation. The transseptal RFA or transaortic retrograde RFA are safe and effective during treatment of mitral AT.
What problem does this paper attempt to address?